Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study
for Post Operative
1 location in Hartford
Sponsor: Hartford Hospital
Sex: Female·Age: 18 - 89
Code: NCT07766837·Phase 2·Recruiting·Listed Aug 17, 2026
Paid Clinical Trials in Hartford, CT
As of September 2026, 230 paid clinical trials are recruiting in Hartford, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hartford offers studies at sites including Hartford Hospital for conditions such as Neuroblastoma, Degenerative Disc Disease, Heart Failure, Sickle Cell Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hartford
Trials by drug in Hartford
Filter results
Filter results
Newly added in Hartford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
for Chronic Kidney Disease
Sites in Hartford, Waterbury +109 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07753993·Phase 3·Recruiting·Listed Aug 10, 2026
206 clinical trials
Get a weekly email when new trials open in Hartford, CT.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Hartford, Waterbury +99 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
Drug: Brenipatide
Sites in Hartford, New Haven +30 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for Pancreatic Cancer
Sites in Hartford +48 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in Hartford +74 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
Sites in Hartford, New Haven +45 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Cancer
Drug: daraxonrasib
Sites in Hartford +42 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Hartford +44 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for Breast Neoplasms
Sites in Hartford, New Haven +47 more locations
Sponsor: Natera, Inc.
Sex: All·Age: 18+
Code: NCT07214532·Recruiting·Listed Oct 2025
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for Endometrial Cancer
Sites in Hartford, Danbury +66 more locations
Sponsor: Genmab
Sex: Female·Age: 18+
Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for Colitis, Ulcerative
Sites in Hartford +49 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 12+
Code: NCT07196748·Phase 3·Recruiting·Listed Sep 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Hartford +90 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
for Metastatic Castration-resistant Prostatic Neoplasms
Drug: Pasritamig
Sites in Hartford +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: Male·Age: 18+
Code: NCT07164443·Phase 3·Recruiting·Listed Sep 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Hartford, West Hartford +2386 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for Non-Small Cell Lung Cancer
Drug: Divarasib
Sites in Hartford +59 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for Metastatic Colorectal Cancer (CRC)
Drug: Bevacizumab
Sites in Hartford, New Haven +100 more locations
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT07228832·Phase 3·Recruiting·Listed Nov 2025
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for Mitral Valve Regurgitation
Sites in Hartford, New Haven +67 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18+
Code: NCT03242642·Recruiting·Listed Aug 2017
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
for Major Depressive Disorder
Sites in Hartford +32 more locations
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 18 - 74
Code: NCT07076407·Phase 3·Recruiting·Listed Jul 2025
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
Sites in Hartford, New Haven +40 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Drug: zolbetuximab
Sites in Hartford, New Haven +35 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT06901531·Phase 3·Recruiting·Listed Mar 2025
Assessment of CCM in HF With Higher Ejection Fraction
for Heart Failure
Sites in Hartford, Danbury +74 more locations
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT05064709·Recruiting·Listed Oct 2021
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for Prostate Cancer
Sites in Hartford +34 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06780670·Phase 2, Phase 3·Recruiting·Listed Jan 2025
Strategy for Improving Stroke Treatment Response
for Ischemic Stroke
Sites in Hartford, New Haven +38 more locations
Sponsor: Translational Sciences, Inc.
Sex: All·Age: 18+
Code: NCT05948566·Phase 2·Recruiting·Listed Jul 2023
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for Heart Failure
Sites in Hartford, New Haven +79 more locations
Sponsor: Cytokinetics
Sex: All·Age: 18 - 85
Code: NCT06736574·Phase 3·Recruiting·Listed Dec 2024
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for Breast Cancer
Sites in Hartford, Glastonbury +100 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025
ELEVATE-HFpEF Clinical Study
for Heart Failure With Preserved Ejection Fraction (HFpEF)
Sites in Hartford +25 more locations
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All·Age: 40+
Code: NCT06678841·Recruiting·Listed Nov 2024
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for Chronic Granulomatous Disease (CGD)
Sites in Hartford +49 more locations
Sponsor: Ensoma
Sex: All·Age: All ages
Code: NCT06605378·Recruiting·Listed Sep 2024
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for Relapsing Multiple Sclerosis
Sites in Hartford, Farmington +107 more locations
Sponsor: TG Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06433752·Recruiting·Listed May 2024
A Study to Assess Growth in Children With Idiopathic Short Stature
for Idiopathic Short Stature
Sites in Hartford +29 more locations
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 2 - 16
Code: NCT06309979·Recruiting·Listed Mar 2024
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for Aortic Stenosis
Sites in Hartford, New Haven +69 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18 - 105
Code: NCT06777368·Recruiting·Listed Jan 2025
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Sites in Hartford +33 more locations
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female·Age: 18+
Code: NCT05128825·Phase 2·Recruiting·Listed Nov 2021
FORWARD CAD IDE Study
for Coronary Arterial Disease (CAD)
Sites in Hartford +27 more locations
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT06662500·Recruiting·Listed Oct 2024
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for Cancer, Metastatic
Sites in Hartford, Norwalk +65 more locations
Sponsor: Massive Bio, Inc.
Sex: All·Age: All ages
Code: NCT03452774·Recruiting·Listed Mar 2018
PARTNER 3 Trial - Aortic Valve-in-Valve
for Aortic Stenosis
Sites in Hartford +28 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: All ages
Code: NCT03003299·Recruiting·Listed Dec 2016
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
for Aortic Dissection
Sites in Hartford +23 more locations
Sponsor: Endospan Ltd.
Sex: All·Age: 18+
Code: NCT04471909·Recruiting·Listed Jul 2020
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for Spinal Muscular Atrophy (SMA)
Sites in Hartford +14 more locations
Sponsor: argenx
Sex: All·Age: 5 - 17
Code: NCT07287982·Phase 2·Recruiting·Listed Dec 2025
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for Somatostatin Receptor Positive (SSTR+)
Sites in Hartford, New Haven +17 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 12 - 100
Code: NCT06784752·Phase 3·Recruiting·Listed Jan 2025
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for Aortic Arch Dissection
Sites in Hartford +17 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT07166133·Recruiting·Listed Sep 2025
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
for Advanced Solid Tumor
Sites in Hartford, New Haven +17 more locations
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT07070232·Phase 1, Phase 2·Recruiting·Listed Jul 2025
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
for Emphysema, Pulmonary
Sites in Hartford +17 more locations
Sponsor: Pulmonx Corporation
Sex: All·Age: 40 - 80
Code: NCT06035120·Recruiting·Listed Sep 2023
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
for Sickle Cell Disease
Sites in Hartford, New Haven +33 more locations
Sponsor: Pfizer
Sex: All·Age: 12+
Code: NCT05431088·Phase 2, Phase 3·Recruiting·Listed Jun 2022
Top Research Study Locations in Hartford
Researchers run research studies in Hartford, CT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hartford Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 59 |
| Connecticut Children's Medical Center | Sickle Cell Disease, Crohn's Disease, Neuroblastoma | 58 |
| Smilow Cancer Hospital Care Center at Saint Francis | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 32 |
| Hartford Healthcare | Opioid Use, Pancreatic Cancer, Advanced Solid Tumor | 13 |
| Connecticut Children's Hospital | Neuroblastoma, Ewing Sarcoma, Osteosarcoma | 7 |
| Connecticut Children's | Glycogen Storage Disease Type I, Glycogen Storage Disease Type IA, Glycogen Storage Disease Type IB | 4 |
| Hartford Healthcare Alliance (Data Collection Only) | Advanced Melanoma, Gastrointestinal Cancer, Glioma | 4 |
| Hartford Healthcare Bone and Joint Institute | Degenerative Disc Disease, Cervical Spinal Instability, Degenerative Scoliosis | 3 |
| Hartford Healthcare Cancer Institute @ Hartford Hospital | Acute Leukemia, Endometrial Cancer, Endometrial Cancer Stage I | 3 |
| Smilow Cancer Hospital at Saint Francis | Breast Cancer, HER2-positive Metastatic Breast Cancer, Metastatic Breast Cancer | 3 |
| Institute of Living | Major Depressive Disorder, Schizophrenia | 2 |
| Olin Neuropsychiatry Research Center | Healthy Volunteers, Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI | 2 |
| Connecticut Children's Medical Center - Hartford | Duchenne Muscular Dystrophy, Crohn's Disease | 2 |
| Hartford HealthCare Cancer Institute | Acute Myeloid Leukemia (AML), Chemotherapy-induced Peripheral Neuropathy, Gynecologic Cancer | 2 |
| Aetna Ambulance Service, Inc | Altered Mental Status, Cardiac Arrest, Heart Failure | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Hypophosphatasia | 1 |
| Connecticut Army National Guard | Suicide | 1 |
| Decentralized / At-Home Participation (U.S.) | Healthy Adult Participants | 1 |
| Hartford Health Care | Atrial Fibrillation (AF), VTE | 1 |
| Hartford Health Hospital | Stroke, Stroke, Acute, Stroke, Ischemic | 1 |
| Hartford HealthCare - Hartford Hospital | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | 1 |
| Hartford HealthCare Cancer Institute at Hartford Hospital | Metastatic Castration-resistant Prostate Cancer | 1 |
| Hartford HealthCare The Bone and Joint Institute | Knee Cap, Knee Cap Injury, Knee Deformity | 1 |
| Hartford Healthcare (Data Collection Only) | HPV-Related Squamous Cell Carcinoma | 1 |
Active & Upcoming Studies in Hartford (2026)
Recruiting trials in Hartford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (94 active studies)
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · Phase 1, Phase 2 · Milton S. Hershey Medical Center
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Cardiovascular (15 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · University of Connecticut
Neurology & pain (12 active studies)
- Interoceptive Awareness and Function in Adolescents With Chronic Pain · Connecticut Children's Medical Center
- MMA Embolization for Refractory Chronic Migraine · Cerenovus, Part of DePuy Synthes Products, Inc.
Pediatric (8 active studies)
- Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease · Connecticut Children's Medical Center
- Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs · Kimberley Roche
Mental health & behavior (5 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs · Kimberley Roche
Diabetes & metabolic (5 active studies)
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · University of Connecticut
- Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy · Hartford HealthCare
Vaccines (1 active study)
Common conditions studied in Hartford
- Neuroblastoma (8 active studies)
- Degenerative Disc Disease (6 active studies)
- Heart Failure (5 active studies)
- Sickle Cell Disease (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Breast Cancer (4 active studies)
Leading research sponsors in Hartford
- National Cancer Institute (NCI)
- Children's Oncology Group
- Connecticut Children's Medical Center
- SWOG Cancer Research Network
- Memorial Sloan Kettering Cancer Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Hartford?
There are approximately 230 recruiting clinical trials in Hartford, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hartford pay participants?
Most recruiting trials in Hartford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hartford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hartford?
The most common conditions under active study in Hartford include Neuroblastoma (8), Degenerative Disc Disease (6), Heart Failure (5), Sickle Cell Disease (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hartford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hartford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hartford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hartford?
Recruiting research sites in Hartford include Hartford Hospital, Connecticut Children's Medical Center, Smilow Cancer Hospital Care Center at Saint Francis, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hartford right now?
The largest active categories in Hartford are Cancer & tumors (94), Cardiovascular (15), Neurology & pain (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Connecticut
New Haven, CT(859)Stamford, CT(84)Waterbury, CT(67)West Haven, CT(62)Trumbull, CT(61)Farmington, CT(59)Waterford, CT(55)Guilford, CT(52)North Haven, CT(52)Fairfield, CT(49)Greenwich, CT(48)Derby, CT(44)Torrington, CT(39)Glastonbury, CT(31)Bridgeport, CT(28)Hamden, CT(25)Norwalk, CT(25)Danbury, CT(23)New Britain, CT(19)Norwich, CT(17)Manchester, CT(15)Orange, CT(15)Cromwell, CT(14)Storrs, CT(14)Milford, CT(11)Meriden, CT(10)Avon, CT(6)Westport, CT(6)Branford, CT(5)Bristol, CT(5)West Hartford, CT(5)Darien, CT(4)Middlebury, CT(4)Bloomfield, CT(3)Middletown, CT(3)Old Saybrook, CT(3)Plainville, CT(2)Brookfield, CT(1)Cheshire, CT(1)Enfield, CT(1)Long Ridge, CT(1)New Britian, CT(1)New London, CT(1)Newhaven, CT(1)Ridgefield, CT(1)Southport, CT(1)Storrs Mansfield, CT(1)Willimantic, CT(1)Wilton, CT(1)